Evotec and Celgene Ink Oncology Deal

Evotec and Celgene entered into a long-term strategic drug discovery and development partnership to identify new therapeutics in oncology.Evotec officials say the firm’s preclinical discovery and development platforms include a phenotypic screening technique “with unique compound libraries and associated target deconvolution capabilities.” The collaboration intends to leverage these capabilities with an initial focus on solid tumors, according to Cord Dohrmann, Ph.D., CSO of Ev